Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sampson

Showing results (221-230 of 393) with videos related to

Pageof 40
Sort By:
Cancer Immunology, Immunotherapy : CII|July 20, 2007
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cellsHidenobu Ochiai, Gary E Archer, James E Herndon, et al.
Radiation Research|April 11, 2025
The Radioprotective Effects of 16, 16 dimethyl Prostaglandin E2 on Survival and Hematopoiesis are Mediated Through Co-Stimulation of the EP3 and EP4 ReceptorsSeiji Fukuda, Andrea M Patterson, Tong Wu, et al.
Health Physics|November 27, 2013
Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivorsHui Lin Chua, P Artur Plett, Carol H Sampson, et al.
Critical Reviews in Oncology/Hematology|October 5, 2010
A comprehensive outlook on intracerebral therapy of malignant gliomasCarlo Buonerba, Giuseppe Di Lorenzo, Alfredo Marinelli, et al.
Radiation Research|August 25, 2025
16,16 dimethyl-prostaglandin E2 Administration Prior to Lethal Irradiation Ameliorates Long-term Immune SuppressionTong Wu, P Artur Plett, Carol H Sampson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Structure of the major peanut allergen Ara h 1 may protect IgE-binding epitopes from degradationS J Maleki, R A Kopper, D S Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in ratsA B Heimberger, G E Archer, R E McLendon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastomaEmil Lou, Scott Turner, Ashley Sumrall, et al.
Neuro-Oncology Advances|April 11, 2022
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143Antonio Omuro, David A Reardon, John H Sampson, et al.
Archives of Biochemistry and Biophysics|June 15, 1997
Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2J S Stanley, N King, A W Burks, et al.
Pageof 40

Showing results (221-230 of 393) with videos related to

Sort By:
Pageof 40
Cancer Immunology, Immunotherapy : CII|July 20, 2007
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cellsHidenobu Ochiai, Gary E Archer, James E Herndon, et al.
Radiation Research|April 11, 2025
The Radioprotective Effects of 16, 16 dimethyl Prostaglandin E2 on Survival and Hematopoiesis are Mediated Through Co-Stimulation of the EP3 and EP4 ReceptorsSeiji Fukuda, Andrea M Patterson, Tong Wu, et al.
Health Physics|November 27, 2013
Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivorsHui Lin Chua, P Artur Plett, Carol H Sampson, et al.
Critical Reviews in Oncology/Hematology|October 5, 2010
A comprehensive outlook on intracerebral therapy of malignant gliomasCarlo Buonerba, Giuseppe Di Lorenzo, Alfredo Marinelli, et al.
Radiation Research|August 25, 2025
16,16 dimethyl-prostaglandin E2 Administration Prior to Lethal Irradiation Ameliorates Long-term Immune SuppressionTong Wu, P Artur Plett, Carol H Sampson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Structure of the major peanut allergen Ara h 1 may protect IgE-binding epitopes from degradationS J Maleki, R A Kopper, D S Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in ratsA B Heimberger, G E Archer, R E McLendon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Bevacizumab-induced reversible posterior leukoencephalopathy syndrome and successful retreatment in a patient with glioblastomaEmil Lou, Scott Turner, Ashley Sumrall, et al.
Neuro-Oncology Advances|April 11, 2022
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143Antonio Omuro, David A Reardon, John H Sampson, et al.
Archives of Biochemistry and Biophysics|June 15, 1997
Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2J S Stanley, N King, A W Burks, et al.
Pageof 40